Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis...

par Tomita T, Norio YF, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S
Publié 2014

Effects of personality on the association between paroxetine plasma concentration and response

par Tomita T, Yasui-Furukori N, Nakagami T, Tsuchimine S, Ishioka M, Kaneda A, Nakamura K
Publié 2018

A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan

par Tsuruga K, Sugawara N, Yasui-Furukori N, Takahashi I, Tsuchimine S, Kaneda A, Nakaji S, Nakamura K
Publié 2014

Reduced plasma orexin-A levels in patients with bipolar disorder

par Tsuchimine S, Hattori K, Ota M, Hidese S, Teraishi T, Sasayama D, Hori H, Noda T, Yoshida S, Yoshida F, Kunugi H
Publié 2019

The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.

par Tetsu Tomita, Norio Yasui-Furukori, Taku Nakagami, Shoko Tsuchimine, Masamichi Ishioka, Ayako Kaneda, Norio Sugawara, Sunao Kaneko
Publié 2014

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder

par Aoki A, Ishiguro S, Watanabe T, Ueda M, Hayashi Y, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K
Publié 2014

MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer's disease.

par Moeko Noguchi-Shinohara, Masato Koike, Hirofumi Morise, Kiwamu Kudo, Shoko Tsuchimine, Junji Komatsu, Chiemi Abe, Sachiko Kitagawa, Yoshihisa Ikeda, Masahito Yamada
Publié 2021

MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer’s disease

par Moeko Noguchi-Shinohara, Masato Koike, Hirofumi Morise, Kiwamu Kudo, Shoko Tsuchimine, Junji Komatsu, Chiemi Abe, Sachiko Kitagawa, Yoshihisa Ikeda, Masahito Yamada
Publié 2021

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia

par Saruwatari J, Yasui-Furukori N, Kamihashi R, Yoshimori Y, Oniki K, Tsuchimine S, Noai M, Sato Y, Nakagami T, Sugawara N, Saito M, Fujii A, Kajiwara A, Mihara S, Ogata Y, Kaneko S, Nakagawa K
Publié 2013